Allergy Therapeutics plc (AIM:AGY)
London · Delayed Price · Currency is GBP · Price in GBX 8.65
+0.75 (9.49%)
Oct 31, 2025, 4:35 PM GMT+1
Allergy Therapeutics Market Cap
Allergy Therapeutics has a market cap or net worth of 412.3 million as of October 31, 2025. Its market cap has increased by 73.00% in one year.
Market Cap
412.30M
Enterprise Value
435.14M
Revenue
55.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.65
Market Cap Chart
Since October 11, 2004, Allergy Therapeutics's market cap has increased from 30.57M to 412.30M, an increase of 1,248.72%. That is a compound annual growth rate of 13.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 412.30M | 33.08% |
| Dec 31, 2024 | 309.82M | 160.00% |
| Dec 29, 2023 | 119.16M | 180.75% |
| Dec 30, 2022 | 42.44M | -79.49% |
| Dec 31, 2021 | 206.98M | 94.57% |
| Dec 31, 2020 | 106.38M | 63.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.37B |
| GSK plc | 71.55B |
| Haleon | 31.54B |
| Smith & Nephew | 11.91B |
| ConvaTec Group | 4.85B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.65B |